Lv1
60 积分 2025-08-29 加入
Meta‐analysis evaluating the efficacy and safety of various Bruton tyrosine kinase (BTK) inhibitors for central nervous system lymphoma: Novel covalent BTK inhibitors, except for ibrutinib, also demonstrate good efficacy in the treatment of primary central nervous system lymphoma
9个月前
已完结
Advances in Primary Central Nervous System Lymphoma
10个月前
已完结
皖公网安备34019202002308
